Vincenzo Serretta

Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients

Paolo Gontero, Richard Sylvester, Francesca Pisano et al. · European Urology · 2014 · 244 citations

Medicine, Oncology, Urology +8

Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions

Vincenzo Serretta, Giuseppe Morgia, Luigi Fondacaro et al. · Urology · 2002 · 229 citations

Medicine, Surgery, Urology +11

NOMOGRAMS INCLUDING NUCLEAR MATRIX PROTEIN 22 FOR PREDICTION OF DISEASE RECURRENCE AND PROGRESSION IN PATIENTS WITH Ta, T1 OR CIS TRANSITIONAL CELL CARCINOMA OF THE BLADDER

Shahrokh F. Shariat, Craig D. Zippe, Gerson Lüdecke et al. · The Journal of Urology · 2005 · 172 citations

Medicine, Oncology, Urology +17

The impact of re‐transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin

Paolo Gontero, Richard Sylvester, Francesca Pisano et al. · British Journal of Urology · 2015 · 153 citations · Full text

Medicine, Surgery, Urology +14

Variability in the Performance of Nuclear Matrix Protein 22 for the Detection of Bladder Cancer

Shahrokh F. Shariat, Michael Marberger, Yair Lotan et al. · The Journal of Urology · 2006 · 103 citations

Medicine, Oncology, Urology +17